Urine myo-inositol as a novel prognostic biomarker for diabetic kidney disease: a targeted metabolomics study using nuclear magnetic resonance
The IRS treats prescribed compounded medicines as Section 213(d) qualified expenses when they are medical care, but some HRA plans now explicitly exclude compounded GLP-1s, and FSA and HSA administrators may require additional substantiation
Rushing BR, Selim MI (2019) Aflatoxin B1: A review on metabolism, toxicity, occurrence in food, occupational exposure, and detoxification methods
Kumar Ponnusamy, Siddarth Srigoku Kumar and Jegathambigai R Naidu (2017)
One study on the fermented version of this ingredient found it could help reduce UVA-induced collagen breakdown
Nikbaf-Shandiz, M., Adeli, S., Faghfouri, A